Exercise of Purchase Warrants Clause Samples

Exercise of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring the Holder(s) to exercise their Purchase Warrants prior to or after the initial filing of any registration statement or the effectiveness thereof.
View SourceView Similar (703)
Exercise of Purchase Warrants. 3.1 INTENTIONALLY LEFT BLANK
View SourceView Similar (3)
Exercise of Purchase Warrants. ...9 3.1 Intentionally Left Blank.. ...9 3.2 Method of Exercise of Purchase Warrants... ...9 3.3 Effect of Exercise of Purchase Warrants...
View SourceView Similar (3)
Exercise of Purchase Warrants. Each Purchase Warrant may be purchased upon delivery to the Company at its principal office, the following: (a) payment of the Warrant Purchase Price, (b) the Subscription Form (attached hereto as Appendix “B” to this Subscription Agreement) providing written notice setting out the number of Purchase Warrants to be purchased, and (c) delivery of the Warrant to Purchase Common Shares of Sockeye Seafood Group, Inc. Upon payment of the Warrant Purchase Price and delivery of the required documentation, the Company will issue and cause to be delivered with all reasonable dispatch to or upon the written order of Subscriber, a certificate or certificates for the number of shares of the Company’s common stock so purchased. The right to purchase represented by the Purchase Warrants shall be exercisable, at the election of the Subscriber thereof, either in full or from time to time in part. In the event the Purchase Warrants are exercised in respect to less than all of the Purchase Warrants convertible prior to the date of expiration thereof, the remaining Purchase Warrants will continue to be subject to adjustment as set forth in herein.
View Source
Exercise of Purchase Warrants. Nothing contained in this Purchase Warrant shall be construed as requiring Aegis to exercise the Purchase Warrant prior to or after the initial filing of any registration statement or the effectiveness thereof.
View Source
Exercise of Purchase Warrants. (a) Each whole P1 Warrant will be exercisable for a period of two years from the Phase 1 Closing Date at an exercise price of $2.50 per Common Share, provided that if the exercise price is lower than the market price permitted under the TSXV rules on the news release date in connection with announcing receipt of the Phase 1 Notice then the exercise price will be increased such that it is equal to the market price as permitted under the TSXV rules. Notwithstanding the foregoing, the P1 Warrants will not be exercisable during the 65 day period immediately following the Phase 1 Closing Date. The Common Shares issuable on exercise of such P1 Warrants will rank pari passu with all Common Shares of the Company issued and outstanding on the date of exercise. (b) Each whole P2 Warrant will be exercisable for a period of two years from the Phase 2 Closing Date at an exercise price equal to 125% of the Phase 2 Purchase Price, provided that if the exercise price is lower than the market price permitted under the TSXV rules on the news release date in connection with announcing receipt of the Phase 2 Notice then the exercise price will be increased such that it is equal to the market price as permitted under the TSXV rules. The Common Shares issuable on exercise of such P2 Warrants will rank pari passu with all Common Shares of the Company issued and outstanding on the date of exercise.
View Source
Exercise of Purchase Warrants 
View Source

Related to Exercise of Purchase Warrants

  • Purchase Warrants The Company hereby agrees to issue to the Representative (and/or its designees) on the Closing Date a warrant (“Representatives’ Warrants”) for the purchase of an aggregate of [__] shares of Common Stock, representing 3% of the number of Firm Shares. The agreement(s) representing the Representatives’ Warrants, in the form attached hereto as Exhibit A (the “Representatives’ Warrant Agreement”), shall be exercisable, in whole or in part, commencing on a date which is six (6) months after the Effective Date and expiring on the five-year anniversary of the Effective Date at an initial exercise price per share of Common Stock of $[__], which is equal to 100.0% of the initial public offering price of the Firm Shares. The Representatives’ Warrant Agreement and the shares of Common Stock issuable upon exercise thereof are hereinafter referred to together as the “Representatives’ Securities.” The Representatives understand and agree that there are significant restrictions pursuant to FINRA Rule 5110 against transferring the Representatives’ Warrant Agreement and the underlying shares of Common Stock during the one hundred and eighty (180) days after the Effective Date and by its acceptance thereof shall agree that it will not sell, transfer, assign, pledge or hypothecate the Representatives’ Warrant Agreement, or any portion thereof, or be the subject of any hedging, short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for a period of one hundred and eighty (180) days following the Effective Date to anyone other than (i) an Underwriter or a selected dealer in connection with the Offering, or (ii) a bona fide officer or partner of the Representatives or of any such Underwriter or selected dealer; and only if any such transferee agrees to the foregoing lock-up restrictions.

  • Purchase Warrant THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of _________ (“Holder”), as registered owner of this Purchase Warrant, to Aytu BioScience, Inc., a Delaware corporation (the “Company”), Holder is entitled, at any time or from time to time from [________________] [DATE THAT IS ONE YEAR FROM THE EFFECTIVE DATE OF THE OFFERING] (the “Commencement Date”), and at or before 5:00 p.m., Eastern time, [____________] [DATE THAT IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the ”Expiration Date”), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [____] shares of common stock of the Company, par value $0.0001 per share (the “Shares”), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[___] per Share [125% of the price of the Shares sold in the Offering]; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall mean the initial exercise price or the adjusted exercise price, depending on the context.